1
Daniel J Capon, Laurence A Lasky: Hybrid immunoglobulins. Genentech, Ginger R Dreger, Carolyn R Adler, May 26, 1992: US05116964 (534 worldwide citation)

Immunoglobulin fusion polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.


2
Daniel J Capon, Laurence A Lasky: Hybrid immunoglobulins. Genentech, Ginger R Dreger, June 27, 1995: US05428130 (280 worldwide citation)

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.


3
Daniel J Capon, Laurence A Lasky: Recombinant DNA encoding hybrid immunoglobulins. Genentech, Ginger R Dreger, May 7, 1996: US05514582 (148 worldwide citation)

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.


4
Daniel J Capon, Laurence A Lasky: Expression vector encoding hybrid immunoglobulins. Genentech, Ginger R Dreger, October 3, 1995: US05455165 (110 worldwide citation)

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.


5
Daniel J Capon, Laurence A Lasky: Hybrid immunoglobulins. Genentech, Jeffrey S Kubinec, February 3, 1998: US05714147 (109 worldwide citation)

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.


6
Daniel J Capon, Laurence A Lasky: Hybrid immunoglobulins. Genentech, Jeffrey S Kubinec, June 18, 2002: US06406697 (50 worldwide citation)

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.


7
Capon Daniel J, Lasky Laurence A: Hybrid immunoglobulins.. Genentech, February 10, 1993: EP0526452-A1 (28 worldwide citation)

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods


8
Capon Daniel J, Lasky Laurence A: Hybrid immunoglobulins for use in therapeutic methods. Genentech, August 23, 2000: EP1029870-A2 (2 worldwide citation)

Novelty polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.


9
Justin Scheer, Wenjun Ouyang, Richard Vandlen, Philip E Hass, Eric Gary Stefanich, Xiaoting Wang: IL-22 Fc fusion proteins. Genentech, Clark & Elbing, Karen L Elbing, November 14, 2017: US09815880 (1 worldwide citation)

The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of using the composition for the treatment of diseases. The invention also relates to IL-22 receptor associated reagents and methods of use thereof ...


10
Fei Mao, Wai Yee Leung, Ching Ying Cheung, Hye Eun Hoover: Heterocycle-substituted xanthene dyes. Biotium, Wilson Sonsini Goodrich & Rosati, February 28, 2017: US09579402 (1 worldwide citation)

The present invention relates to fluorescent dyes in general. The present invention provides a wide range of fluorescent dyes and kits containing the same, which are applicable for labeling a variety of biomolecules, cells and microorganisms. The present invention also provides various methods of us ...